GGrantIndex
← Search

Pathology Network Shared Resource

$253,466P30FY2023CANIH

Roswell Park Cancer Institute Corp, Buffalo NY

Investigators

Linked publications, trials & patents

Trial NCT07082270Trial NCT06202066Trial NCT05589844Trial NCT05338905Trial NCT05292521Trial NCT05231122Trial NCT04607291Trial NCT04533542Trial NCT04530812Trial NCT04526587Trial NCT04379518Trial NCT04358315Trial NCT04348747Trial NCT04298606Trial NCT04290962Trial NCT04269213Trial NCT04231539Trial NCT04207190Trial NCT04119830Trial NCT04110249Trial NCT04109924Trial NCT04093323Trial NCT04081389Trial NCT04073745Trial NCT04068649Trial NCT04067830Trial NCT04060446Trial NCT04032418Trial NCT04000581Trial NCT03965234Trial NCT03935347Trial NCT03899987Trial NCT03897270Trial NCT03895918Trial NCT03881735Trial NCT03880422Trial NCT03879694Trial NCT03865472Trial NCT03851081Trial NCT03793907Trial NCT03789877Trial NCT03751449Trial NCT03751436Trial NCT03736720Trial NCT03735589Trial NCT03735095Trial NCT03727789Trial NCT03727061Trial NCT03709550Trial NCT03691376Trial NCT03688945Trial NCT03685695Trial NCT03683147Trial NCT03680235Trial NCT03679585Trial NCT03679559Trial NCT03678350Trial NCT03630601Trial NCT03574792Trial NCT03457142Trial NCT03403634Trial NCT03384836Trial NCT03358719Trial NCT03348748Trial NCT03333486Trial NCT03297489Trial NCT03211416Trial NCT03206047Trial NCT03192397Trial NCT03090412Trial NCT03017131Trial NCT03011736Trial NCT02965976Trial NCT02955290Trial NCT02953457Trial NCT02947386Trial NCT02877641Trial NCT02857374Trial NCT02853318Trial NCT02833506Trial NCT02713373Trial NCT02650986Trial NCT02575885Trial NCT02575508Trial NCT02531906Trial NCT02474095Trial NCT02455557Trial NCT02452463Trial NCT02414724Trial NCT02399215Trial NCT02393755Trial NCT02334865Trial NCT02287727Trial NCT02227940Trial NCT02170389Trial NCT02166905Trial NCT02159950Trial NCT02119728Trial NCT02100254Trial NCT02072486

Abstract

The Pathology Network Shared Resource (PNSR) provides human specimens and laboratory services for basic and translational research to further the understanding of the pathogenesis of human cancers and facilitate discovery of biomarkers for new precision medicine approaches. The overall mission of the PNSR is to facilitate collection and access to bio-specimens for research conducted at Roswell Park Comprehensive Cancer Center. The PNSR provides five key service areas: Procurement, Pathology Core Services, Correlative Science Pathology Office, Bio-specimen Bank, and Image Analysis. In the reporting period (2013-2017), the PNSR served a total of 202 Roswell users, of which 131 (88%) were CCSG members. The Specific Aims of the PNSR are: 1) To consent, collect, and store high quality tumor bio specimens. The PNSR oversees the consenting and collection of tumor specimens under a highly standardized process with IRB approval. This includes both routine surgical collections as well as specialized collections of metastatic disease, fresh tissue, or longitudinal collections in accordance with specific clinical protocols; 2) To provide state-of-the-art tissue analyses platforms. The PNSR provides a robust suite of tissue analysis tools to enable the comprehensive analysis of tissues. Standard histology and immunohistochemistry services are complemented by laser capture microdissection and spectral karyotyping; 3) To provide expertise for study design, grant preparation, and clinical trials. Staff within the PNSR plays an active role in designing biomarker studies and rigorous methods for evaluating data that emerges from the analysis of tissues. These integrated features of the PNSR provide an important platform for grant submissions and facilitate development of correlative studies in the context of clinical trials. There are limited options for bio specimen acquisition with the level of quality and annotation that is provided by the PNSR. Acquiring fresh or frozen tissue from external tissue banks is costly, requires considerable legal work (e.g. MTAs), and reliability can be questionable, our costs for these activities in comparison to external sites provide more affordable service for CCSG members. Furthermore, the convenience of these resources is an added benefit to investigators in terms of saving them time and ease of discussion related to design and interpretation of data. Services within the PNSR are accessible to any researcher that has appropriate IRB approval for the proposed work. The PNSR plans to be at the forefront in all areas of operation to facilitate cutting-edge research that will lead to significant changes in the prevention and treatment of cancer. Specialized procurement is critical for this goal given the importance of understanding metastatic, recurrent, and therapy resistant disease.

View original record on NIH RePORTER →